Zentalis Pharmaceuticals, Inc. (ZNTL)
1.695
+0.02
(+0.89%)
USD |
NASDAQ |
Nov 13, 16:00
1.695
0.00 (0.00%)
After-Hours: 19:59
Zentalis Pharmaceuticals Price to Book Value : 0.8129 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 0.8057 |
| November 11, 2026 | 0.9064 |
| November 10, 2026 | 0.8633 |
| November 09, 2026 | 0.8345 |
| November 06, 2026 | 0.8249 |
| November 05, 2026 | 0.8201 |
| November 04, 2026 | 0.8441 |
| November 03, 2026 | 0.8537 |
| November 02, 2026 | 0.8872 |
| October 30, 2026 | 0.94 |
| October 29, 2026 | 0.9544 |
| October 28, 2026 | 0.9879 |
| October 27, 2026 | 0.9496 |
| October 26, 2026 | 0.9927 |
| October 23, 2026 | 1.060 |
| October 22, 2026 | 1.156 |
| October 21, 2026 | 1.132 |
| October 20, 2026 | 1.146 |
| October 19, 2026 | 1.103 |
| October 16, 2026 | 1.022 |
| October 15, 2026 | 1.074 |
| October 14, 2026 | 1.113 |
| October 13, 2026 | 1.151 |
| October 12, 2026 | 1.209 |
| October 09, 2026 | 1.266 |
| Date | Value |
|---|---|
| October 08, 2026 | 1.204 |
| October 07, 2026 | 1.223 |
| October 06, 2026 | 1.280 |
| October 05, 2026 | 1.333 |
| October 02, 2026 | 1.209 |
| October 01, 2026 | 1.249 |
| September 30, 2026 | 1.328 |
| September 29, 2026 | 1.355 |
| September 28, 2026 | 1.297 |
| September 25, 2026 | 1.347 |
| September 24, 2026 | 1.372 |
| September 23, 2026 | 1.432 |
| September 22, 2026 | 1.537 |
| September 21, 2026 | 1.512 |
| September 18, 2026 | 1.552 |
| September 17, 2026 | 1.537 |
| September 16, 2026 | 1.547 |
| September 15, 2026 | 1.562 |
| September 14, 2026 | 1.746 |
| September 11, 2026 | 1.751 |
| September 10, 2026 | 1.791 |
| September 09, 2026 | 1.896 |
| September 08, 2026 | 2.011 |
| September 04, 2026 | 1.991 |
| September 03, 2026 | 2.051 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ARS Pharmaceuticals, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 2.334 |
| Alnylam Pharmaceuticals, Inc. | 6.130 |
| Anika Therapeutics, Inc. | 1.299 |
| Savara, Inc. | 8.833 |
Price to Book Value Related Metrics
| Price | 1.695 |
| Earnings Yield | -113.7% |
| Market Cap | 166.55M |